Regeneron PharmaceuticalsREGN 
$714.47-0.09%24h
-0.09%24h
Global rank201
Market cap$76.54B
Change 7d-2.82%
YTD Performance-
SP500 benchmark
P/E0
P/S5.84
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals (REGN) Net Assets
REGN Net Assets in 2024: $25.97B
As of 25 Jan 2025, Regeneron Pharmaceuticals net assets is $25.97B, an increase of 14.60% to 2023. Net assets are calculated as total assets minus total liabilities. This value represents the Regeneron Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Regeneron Pharmaceuticals Net Assets History from 2018 to 2025
-
Value:-
REGN Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $25.97B | 14.60% |
| 2022 | $22.66B | 20.75% |
| 2021 | $18.77B | 70.23% |
| 2020 | $11.03B | -0.58% |
| 2019 | $11.09B | 111.55% |
| 2018 | $5.24B | - |
View the Top Net Assets Companies
